Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Shenzhen Chipscreen Biosciences Co Ltd
SSE:688321
Price:
16.26
CNY
-2.46%
Market Closed
Market Cap:
6.6B
CNY
Income Statement
Earnings Waterfall
Shenzhen Chipscreen Biosciences Co Ltd
Shenzhen Chipscreen Biosciences Co Ltd
|
Revenue
|
656.2m
CNY
|
|
Cost of Revenue
|
-90.3m
CNY
|
|
Gross Profit
|
566m
CNY
|
|
Operating Expenses
|
-588.3m
CNY
|
|
Operating Income
|
-22.3m
CNY
|
|
Other Expenses
|
-48m
CNY
|
|
Net Income
|
-70.3m
CNY
|
Income Statement
Shenzhen Chipscreen Biosciences Co Ltd
Shenzhen Chipscreen Biosciences Co Ltd
Currency: CNY
Millions
TTM
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Revenue |
148
N/A
|
142
-4%
|
157
+10%
|
181
+15%
|
174
-4%
|
181
+4%
|
202
+12%
|
231
+14%
|
270
+17%
|
312
+16%
|
342
+10%
|
360
+5%
|
430
+20%
|
460
+7%
|
463
+1%
|
490
+6%
|
530
+8%
|
532
+0%
|
556
+4%
|
543
-2%
|
524
-4%
|
548
+5%
|
584
+7%
|
656
+12%
|
|
| Gross Profit | |||||||||||||||||||||||||
| Cost of Revenue |
(6)
|
(8)
|
(8)
|
(9)
|
(7)
|
(11)
|
(12)
|
(14)
|
(14)
|
(18)
|
(19)
|
(20)
|
(22)
|
(29)
|
(34)
|
(38)
|
(30)
|
(41)
|
(47)
|
(51)
|
(57)
|
(71)
|
(79)
|
(90)
|
|
| Gross Profit |
142
N/A
|
135
-5%
|
149
+11%
|
172
+15%
|
167
-3%
|
171
+2%
|
191
+12%
|
217
+14%
|
256
+18%
|
294
+15%
|
323
+10%
|
340
+5%
|
409
+20%
|
431
+5%
|
430
0%
|
452
+5%
|
500
+11%
|
491
-2%
|
508
+4%
|
491
-3%
|
467
-5%
|
477
+2%
|
506
+6%
|
566
+12%
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(114)
|
(110)
|
(120)
|
(136)
|
(155)
|
(162)
|
(179)
|
(198)
|
(235)
|
(285)
|
(335)
|
(374)
|
(394)
|
(406)
|
(421)
|
(456)
|
(483)
|
(498)
|
(594)
|
(590)
|
(636)
|
(627)
|
(571)
|
(588)
|
|
| Selling, General & Administrative |
(80)
|
(79)
|
(84)
|
(88)
|
(107)
|
(115)
|
(130)
|
(149)
|
(161)
|
(201)
|
(235)
|
(270)
|
(285)
|
(293)
|
(299)
|
(307)
|
(316)
|
(331)
|
(364)
|
(361)
|
(368)
|
(370)
|
(367)
|
(388)
|
|
| Research & Development |
(43)
|
(42)
|
(45)
|
(52)
|
(51)
|
(55)
|
(65)
|
(69)
|
(91)
|
(107)
|
(115)
|
(126)
|
(125)
|
(141)
|
(148)
|
(167)
|
(156)
|
(180)
|
(250)
|
(246)
|
(258)
|
(270)
|
(210)
|
(207)
|
|
| Depreciation & Amortization |
(4)
|
(1)
|
0
|
0
|
(3)
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(23)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
13
|
12
|
9
|
4
|
6
|
8
|
16
|
21
|
24
|
22
|
15
|
22
|
28
|
27
|
26
|
18
|
11
|
14
|
20
|
17
|
15
|
13
|
7
|
6
|
|
| Operating Income |
28
N/A
|
24
-14%
|
29
+19%
|
36
+23%
|
11
-69%
|
9
-19%
|
12
+32%
|
20
+65%
|
21
+5%
|
9
-58%
|
(12)
N/A
|
(34)
-178%
|
15
N/A
|
25
+62%
|
8
-67%
|
(5)
N/A
|
17
N/A
|
(7)
N/A
|
(86)
-1 161%
|
(98)
-15%
|
(169)
-72%
|
(150)
+11%
|
(65)
+56%
|
(22)
+66%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
4
|
4
|
4
|
5
|
11
|
17
|
21
|
20
|
16
|
14
|
10
|
9
|
7
|
2
|
4
|
6
|
(0)
|
(6)
|
280
|
270
|
(23)
|
263
|
(35)
|
(40)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
289
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(4)
|
(4)
|
(3)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
0
|
1
|
|
| Pre-Tax Income |
32
N/A
|
28
-13%
|
32
+14%
|
41
+26%
|
21
-49%
|
25
+20%
|
31
+27%
|
38
+21%
|
36
-5%
|
22
-39%
|
(4)
N/A
|
(29)
-614%
|
19
N/A
|
23
+24%
|
10
-58%
|
0
-95%
|
15
+3 272%
|
(13)
N/A
|
194
N/A
|
172
-12%
|
97
-43%
|
113
+16%
|
(101)
N/A
|
(62)
+39%
|
|
| Net Income | |||||||||||||||||||||||||
| Tax Provision |
(1)
|
(0)
|
(1)
|
(4)
|
(1)
|
(2)
|
(1)
|
(1)
|
(5)
|
(4)
|
(1)
|
(3)
|
3
|
3
|
0
|
2
|
(2)
|
(6)
|
(46)
|
(46)
|
(48)
|
(46)
|
(7)
|
(9)
|
|
| Income from Continuing Operations |
31
|
28
|
31
|
37
|
19
|
23
|
31
|
37
|
31
|
19
|
(5)
|
(32)
|
22
|
26
|
10
|
2
|
13
|
(19)
|
148
|
125
|
49
|
67
|
(108)
|
(70)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
8
|
44
|
43
|
40
|
36
|
0
|
0
|
|
| Net Income (Common) |
31
N/A
|
28
-11%
|
31
+11%
|
37
+20%
|
19
-47%
|
23
+19%
|
31
+32%
|
37
+21%
|
31
-16%
|
19
-40%
|
(5)
N/A
|
(32)
-558%
|
22
N/A
|
26
+16%
|
10
-62%
|
4
-59%
|
17
+337%
|
(11)
N/A
|
192
N/A
|
168
-13%
|
89
-47%
|
103
+16%
|
(108)
N/A
|
(70)
+35%
|
|
| EPS (Diluted) |
0.09
N/A
|
0.07
-22%
|
0.07
N/A
|
0.09
+29%
|
0.05
-44%
|
0.06
+20%
|
0.08
+33%
|
0.09
+13%
|
0.08
-11%
|
0.04
-50%
|
-0.02
N/A
|
-0.08
-300%
|
0.05
N/A
|
0.06
+20%
|
0.02
-67%
|
0.01
-50%
|
0.04
+300%
|
-0.02
N/A
|
0.48
N/A
|
0.42
-13%
|
0.22
-48%
|
0.26
+18%
|
-0.26
N/A
|
-0.17
+35%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
